INSIGHT SPONSOR
We are grateful for the support of our Sponsor Wyeth. As always, Nature carries sole responsibility for all editorial content.
Top of pageProduced with support from: Wyeth
At Wyeth we are building a different kind of drug discovery organization. Our world-class pipeline is supported by the superior research and development that is critical to introducing the most effective pharmaceuticals. At Wyeth we understand that scientific excellence comes from the freedom to explore scientific concepts, to publish in peer-reviewed journals, to attend international scientific meetings, and to collaborate with the best researchers across the globe.
Our focus on scientific excellence, combined with a culture that is passionate about bringing new medicines to the clinic, has allowed us to develop one of the worlds most productive and innovative research pipelines across the disciplines of inflammation, neuroscience, cardiovascular diseases, oncology and women's health.
Our early stage pipeline is innovative and dynamic and encompasses both small molecule and biopharmaceutical approaches. Indeed, Wyeth has made significant investment in biopharmaceuticals, from research through to global scale manufacturing. Wyeth has a distinguished record of discovery, clinical development and manufacturing of innovative small molecule and protein therapies both within autoimmune diseases and in other therapeutic areas including hemophilia, oncology and bone repair.
To learn more about the exciting opportunities at Wyeth visit: www.wyeth.com
